News
- Author:
- Bruce Jancin
Publish date: January 2, 2018
DENVER – FAME 2 trial 3-year outcomes deemed “compelling.”
News
- Author:
- Bruce Jancin
Publish date: January 2, 2018
CHICAGO – Current Procedural Terminology coding for endovascular aneurysm repair has been totally overhauled for 2018 with the introduction of a fa...
News
- Author:
- Bruce Jancin
Publish date: December 26, 2017
GENEVA – “Those are the lupus patients who still die today.”
News
- Author:
- Bruce Jancin
Publish date: December 15, 2017
GENEVA – IL-23 inhibitor achieves consistent skin outcomes in psoriasis with and without arthritis.
News
- Author:
- Bruce Jancin
Publish date: December 12, 2017
GENEVA –Three positive phase 2 trials of JAK inhibitors in patients with atopic dermatitis generated excitement at the EADV congress.
News
- Author:
- Bruce Jancin
Publish date: December 11, 2017
Most patients with moderate to severe plaque psoriasis on either guselkumab or tildrakizumab have at least PASI 90 sustained response at 2 years.
News
- Author:
- Bruce Jancin
Publish date: December 7, 2017
Studies are shining a new light on alcoholism, coffee, smoking, the genetics of pathological gambling, and more.
News
- Author:
- Bruce Jancin
Publish date: December 7, 2017
The Bruton tyrosine kinase inhibitor is also under study for other autoimmune diseases.
News
- Author:
- Bruce Jancin
Publish date: December 3, 2017
Cardiologists hail less depression, better physical function for up to a year.
News
- Author:
- Bruce Jancin
Publish date: December 2, 2017
DENVER – SENIOR trial results spell end of the line for BMS.
News
- Author:
- Bruce Jancin
Publish date: December 1, 2017
PARIS – The connection, seen more often among men, ‘suggests a common biological basis’ for developing the two disorders.
News
- Author:
- Bruce Jancin
Publish date: November 30, 2017
Forty percent of U.S. patients aren’t even at the minimum therapeutic dose within 4 weeks of diagnosis.
News
- Author:
- Bruce Jancin
Publish date: November 30, 2017
The hope is that resetting the circadian clock will improve ADHD symptoms in children and adults with the disorder.
News
- Author:
- Bruce Jancin
Publish date: November 29, 2017
Small pilot study suggests that most patients treated with a single 10-mg dose experience a significant drop on the Excited Component of the PANSS....
News
- Author:
- Bruce Jancin
Publish date: November 28, 2017
All-cause mortality is significantly higher than it is among patients with non–treatment-resistant major depressive disorder.
